FDA Adjusts Booster Advice News | January 3, 2022 | 0 | by Morgan McCarthy The FDA is authorizing Pfizer boosters for 12-to-15-year-olds amid a surge in COVID cases, driven by the Omicron variant. Sara Lee Kessler with details.